Market closed

XOMA/$XOMA

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About XOMA

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Ticker

$XOMA

Sector

Health Care

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

EmeryVille, United States

Employees

Website

xoma.com

XOMA Metrics

BasicAdvanced

$299M

-

-$3.05

0.90 -

Price and volume

Market cap

$299M

Beta

0.9

52-week high

$33.31

52-week low

$18.57

Average daily volume

32K

Financial strength

Current ratio

7.524

Quick ratio

7.408

Long term debt to equity

128.15

Total debt to equity

140.248

Interest coverage (TTM)

-1.40%

Management effectiveness

Return on assets (TTM)

-5.54%

Return on equity (TTM)

-31.41%

Valuation

Price to revenue (TTM)

13.643

Price to book

3.52

Price to tangible book (TTM)

3.52

Price to free cash flow (TTM)

-14.537

Growth

Revenue change (TTM)

389.82%

Earnings per share change (TTM)

8.75%

3-year revenue growth (CAGR)

-10.16%

3-year earnings per share growth (CAGR)

233.67%

What the Analysts think about XOMA

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for XOMA stock.

XOMA Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

XOMA Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

XOMA News

AllArticlesVideos

XOMA Royalty Declares Quarterly Preferred Stock Dividends

GlobeNewsWire·4 weeks ago

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

GlobeNewsWire·2 months ago

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

GlobeNewsWire·3 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XOMA

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for XOMA stock?

XOMA (XOMA) has a market cap of $299M as of January 15, 2025.

What is the P/E ratio for XOMA stock?

The price to earnings (P/E) ratio for XOMA (XOMA) stock is 0 as of January 15, 2025.

Does XOMA stock pay dividends?

No, XOMA (XOMA) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next XOMA dividend payment date?

XOMA (XOMA) stock does not pay dividends to its shareholders.

What is the beta indicator for XOMA?

XOMA (XOMA) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.